Page last updated: 2024-08-24

irinotecan and Hodgkin Disease

irinotecan has been researched along with Hodgkin Disease in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	2 (50.00)	18.2507
2000's	1 (25.00)	29.6817
2010's	1 (25.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Benoit, LT; Cochran, JH; Emmerton, KK; Lau, UY; Senter, PD; Stevens, NS; Zaval, M	1
Fujimoto, K; Kaneki, T; Koizumi, T; Kubo, K; Urushihata, K; Yamaguchi, S	1
Ariyoshi, Y; Furue, H; Kimura, I; Masaoka, T; Ogawa, M; Oguro, M; Ohno, R; Saito, H; Sakai, Y; Yoshida, Y	1
Eckhardt, SG	1

Trials

1 trial(s) available for irinotecan and Hodgkin Disease

Article	Year
[An early phase II study of CPT-11 (irinotecan hydrochloride) in patients with hematological malignancies]. Gan to kagaku ryoho. Cancer & chemotherapy, 1994, Volume: 21, Issue:1 Topics: Adolescent; Adult; Aged; Antineoplastic Agents, Phytogenic; Camptothecin; Diarrhea; Drug Administration Schedule; Female; Hodgkin Disease; Humans; Irinotecan; Leukemia, Myeloid, Acute; Lymphoma, Non-Hodgkin; Male; Nausea; Precursor Cell Lymphoblastic Leukemia-Lymphoma	1994

Article

Year

[An early phase II study of CPT-11 (irinotecan hydrochloride) in patients with hematological malignancies].

Gan to kagaku ryoho. Cancer & chemotherapy, 1994, Volume: 21, Issue:1

Topics: Adolescent; Adult; Aged; Antineoplastic Agents, Phytogenic; Camptothecin; Diarrhea; Drug Administration Schedule; Female; Hodgkin Disease; Humans; Irinotecan; Leukemia, Myeloid, Acute; Lymphoma, Non-Hodgkin; Male; Nausea; Precursor Cell Lymphoblastic Leukemia-Lymphoma

1994

Other Studies

3 other study(ies) available for irinotecan and Hodgkin Disease

Article	Year
Lactone Stabilization is Not a Necessary Feature for Antibody Conjugates of Camptothecins. Molecular pharmaceutics, 2018, 09-04, Volume: 15, Issue:9 Topics: Animals; Antibodies; Antineoplastic Agents, Phytogenic; Camptothecin; Cell Line, Tumor; Hodgkin Disease; Humans; Hydrogen-Ion Concentration; Irinotecan; Lactones; Mice; Mice, SCID; Pharmacokinetics	2018
Successful salvage therapy of irinotecan for relapsed Hodgkin's lymphoma. Internal medicine (Tokyo, Japan), 2002, Volume: 41, Issue:8 Topics: Adult; Antineoplastic Agents; Camptothecin; Enzyme Inhibitors; Hodgkin Disease; Humans; Irinotecan; Male; Radiography; Recurrence; Salvage Therapy; Topoisomerase I Inhibitors	2002
Irinotecan: a review of the initial phase I trials. Oncology (Williston Park, N.Y.), 1998, Volume: 12, Issue:8 Suppl 6 Topics: Antineoplastic Agents, Phytogenic; Camptothecin; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Dose-Response Relationship, Drug; Drug Administration Schedule; France; Hodgkin Disease; Humans; Irinotecan; Japan; Leukemia; Lymphoma, Non-Hodgkin; United States	1998